HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.

AuthorsMasaki Kato, Naoya Shimohashi, Jiro Ouchi, Kisaku Yoshida, Yuichi Tanabe, Kenji Takenaka, Makoto Nakamuta
JournalJournal of gastroenterology (J Gastroenterol) Vol. 40 Issue 11 Pg. 1076-7 (Nov 2005) ISSN: 0944-1174 [Print] Japan
PMID16322955 (Publication Type: Letter)
Chemical References
  • Antiviral Agents
  • Immunologic Factors
  • Interferon-alpha
Topics
  • Antiviral Agents (therapeutic use)
  • Blood Cell Count
  • Embolization, Therapeutic
  • Female
  • Hepatitis C, Chronic (blood, complications, therapy)
  • Humans
  • Hypersplenism (complications, therapy)
  • Immunologic Factors (therapeutic use)
  • Interferon-alpha (therapeutic use)
  • Male
  • Middle Aged
  • Splenic Artery

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: